Skip to main content

European Archives of Psychiatry and Clinical Neuroscience

Ausgabe 1/2023

Inhalt (24 Artikel)

Original Paper

Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis

Yazmin Hernández-Díaz, Carlos Alfonso Tovilla-Zárate, Rosa Giannina Castillo-Avila, Isela Esther Juárez-Rojop, Alma Delia Genis-Mendoza, María Lilia López-Narváez, Guillermo Efrén Villar-Juárez, Thelma Beatriz González-Castro

Original Paper

Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD

Gabriela Pessin Meyer, Bruna Santos da Silva, Cibele Edom Bandeira, Maria Eduarda Araujo Tavares, Renata Basso Cupertino, Eduarda Pereira Oliveira, Diana Müller, Djenifer B. Kappel, Stefania Pigatto Teche, Eduardo Schneider Vitola, Luis Augusto Rohde, Diego Luiz Rovaris, Eugenio Horacio Grevet, Claiton Henrique Dotto Bau

Open Access Original Paper

Working memory dysfunction in fibromyalgia is associated with genotypes of the catechol- O-methyltransferase gene: an event-related potential study

David Ferrera, Francisco Gómez-Esquer, Irene Peláez, Paloma Barjola, Roberto Fernandes-Magalhaes, Alberto Carpio, María Eugenia De Lahoz, María Carmen Martín-Buro, Francisco Mercado

Original Paper

Temperament traits mediate the relationship between CACNA1C polymorphisms and bipolar disorder in cisgender women

Clarissa Ribeiro Bastos, Bertha Bueno Bock, Janaina Xavier, Laísa Camerini, Samantha Seibt Dewes, Mateus Grellert, Hudson Wander de Carvalho, Karen Jansen, Ricardo Azevedo da Silva, Ricardo Tavares Pinheiro, Luciano de Mattos Souza, Jean Pierre Oses, Luis Valmor Portela, Diogo Rizzato Lara, Luciana Tovo-Rodrigues, Gabriele Ghisleni

Open Access Original Paper

Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited

Lucie Bartova, Markus Dold, Hans-Peter Volz, Erich Seifritz, Hans-Jürgen Möller, Siegfried Kasper

Open Access Original Paper

Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data

Mateo de Bardeci, Waldemar Greil, Hans Stassen, Jamila Willms, Ursula Köberle, René Bridler, Gregor Hasler, Siegfried Kasper, Eckart Rüther, Stefan Bleich, Sermin Toto, Renate Grohmann, Johanna Seifert

Open Access Original Paper

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

X. M. Hart, S. Heesen, C. N. Schmitz, S. Dörfler, D. Wedekind, G. Gründer, C. Hiemke, U. Havemann-Reinecke

Open Access Original Paper

Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol

Esther Dechantsreiter, Frank Padberg, Alon Morash, Ulrike Kumpf, Arthur Nguyen, Zeno Menestrina, Fabienne Windel, Gerrit Burkhardt, Stephan Goerigk, Takuya Morishita, Aldo Soldini, Shira Ahissar, Tamar Cohen, Angela Pasqualotto, Linda Rubene, Liene Konosonoka, Daniel Keeser, Peter Zill, Razan Assi, Rémy Gardier, Roser Viñals, Jean-Philippe Thiran, Ronen Segman, Yuval Benjamini, Omer Bonne, Friedhelm Christoph Hummel, Daphne Bavelier, Elmars Rancans, Mor Nahum

Original Paper

Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation

Haejin Hong, Rye Young Kim, Yumi Song, Chaewon Suh, Hyangwon Lee, In Kyoon Lyoo, Sujung Yoon, Soo Mee Lim, Suji Lee

Open Access Original Paper

Predicting treatment outcome in depression: an introduction into current concepts and challenges

Nicolas Rost, Elisabeth B. Binder, Tanja M. Brückl

Original Paper

Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis

Irina S. Boksha, Maria A. Omel’chenko, Olga K. Savushkina, Tatyana A. Prokhorova, Elena B. Tereshkina, Elena A. Vorobyeva, Gulnur Sh. Burbaeva

Original Paper

Aberrant temporal–spatial complexity of intrinsic fluctuations in major depression

Kaizhong Zheng, Baojuan Li, Hongbing Lu, Huaning Wang, Jin Liu, Baoyu Yan, Karl J. Friston, Yuxia Wu, Jian Liu, Xi Zhang, Mengwan Liu, Liang Li, Jian Qin, Badong Chen, Dewen Hu, Lingjiang Li

Original Paper

Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study

Chuanyi Kang, Jiacheng Liu, Yue Zheng, Xiaohong Wang, Liying Yang, Siyu Qiu, Ying Zhao, Blake N. Lackey, Hanjing Emily Wu, Na Zhao, Xiangyang Zhang

Open Access Original Paper

No effects of acute tryptophan depletion on anxiety or mood in weight-recovered female patients with anorexia nervosa

Tomas Weinert, Fabio Bernardoni, Joseph King, Julius Steding, Ilka Boehm, Merle Mannigel, Franziska Ritschel, Florian Zepf, Veit Roessner, Stefan Ehrlich

Original Paper

Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis

Jose Contador, Ana Magdalena Vargas-Martínez, Raquel Sánchez-Valle, Marta Trapero-Bertran, Albert Lladó

Open Access Original Paper

The neural signatures of psychoses in Alzheimer’s disease: a neuroimaging genetics approach

Riccardo Manca, Antonio F. Pardiñas, Annalena Venneri

Open Access Original Paper

Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice

Martina Stazi, Silvia Zampar, Madeleine Nadolny, Luca Büschgens, Thomas Meyer, Oliver Wirths

Short Communication

Canonical insulin signaling is not significantly impaired in early stages of depression

Deepti Singh, Henrik Dobrowolny, Dimitrios Kapogiannis, Johann Steiner

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.